Full text is available at the source.
Abstract
HMB treatment of C2C12 myotubes resulted in activation of P70S6K and S6 without activating AKT and mTOR.
- HMB is a breakdown product of leucine known to promote muscle growth.
- Previous studies have shown conflicting evidence regarding HMB's activation of AKT and mTOR.
- In this study, HMB treatment resulted in the activation of P70S6K and S6, but not AKT and mTOR.
- The activation of P70S6K and S6 occurred even with the presence of inhibitors of mTOR.
- HMB treatment also led to increased activation of phospholipase D2 (PLD).
- HMB was associated with high amplitude and advanced circadian rhythms.
Simplified